PROCEPT BioRobotics Obtains $42,000,000 New Funding

  • Feed Type
  • Date
    7/8/2015
  • Company Name
    PROCEPT BioRobotics
  • Mailing Address
    900 Island Dr. Redwood Shores, CA 94065 USA
  • Company Description
    PROCEPT BioRobotics is a medical device company that develops a novel minimally invasive technology to surgically treat prostate disease. The first product developed is the AquaBeam, an intelligent image-guided robotic system delivering Aquablation, a personalized waterjet tissue resection modality.
  • Website
    http://www.procept-biorobotics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $42,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    PROCEPT will use the proceeds from the financing for a limited commercial launch of AquaBeam in targeted international markets and to conduct the WATER study (Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue), a randomized blinded controlled clinical trial.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy